Dr. Ankur Bahl

Name - Dr. Ankur Bahl

    education Education


 He has also completeda course on Adverse Drug Reactions, Drug Interactions and Pharma covigilance at the University of Oxford UK. Dr. Bahl holds clinical expertise inImmunotherapy, targeted therapies in combination with Chemotherapy,Hormonal Therapy, Supportive and Palliative Care. 

 He is the lead author of largest real world Indian data on targeted therapy(Cetuxmab) in Head & Neck cancer, Acute Myeloid Leukaemia Treatment,Human Pappiloma Virus trends in Indian Population etc. He is also the leadfounder of various innovative oncology educational platforms and networks(International and national) Evidence based debates in oncology, Live Oncology Tumour boards, Master Classes andworkshops in oncology Dr Bahl has joined FMRI, Gurugram from Max Hospital, Saket where he was Director- Medical Oncology and HaematologyOncology, Previously he was associated with prestigious organisation like Rajiv Gandhi Cancer Institute and ResearchCentre and Maulana Azad Medical College.



Medical Oncology